분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2011-09-21 09:29:36 , Hit : 2317
 Researchers discover a switch that controls stem cell pluripotency

Public release date: 15-Sep-2011
[ Print | E-mail |  Share ] [ Close Window ]

Contact: Jim Oldfield
jim.oldfield@utoronto.ca
416-946-8423
University of Toronto

Toronto—Scientists have found a control switch that regulates stem cell "pluripotency," the capacity of stem cells to develop into any type of cell in the human body. The discovery reveals that pluripotency is regulated by a single event in a process called alternative splicing.

Alternative splicing allows one gene to generate many different genetic messages and protein products. The researchers found that in genetic messages of a gene called FOXP1, the switch was active in embryonic stem cells but silent in "adult" cells—those that had become the specialized cells that comprise organs and perform functions.

"It opens the field to the fact that alternative splicing plays a really important role in stem cell pluripotency," said Prof. Benjamin Blencowe, principal investigator on the study and a Professor in the University of Toronto's Departments of Molecular Genetics and Banting and Best Department of Medical Research. "We're beginning to see an entirely new landscape of regulation, which will be crucial to our understanding of how to produce more effective pluripotent stem cells for therapeutic and research applications."

The findings were published in the current online edition of the scientific journal Cell.

Alternative splicing works by allowing different segments of genetic messages, also known as messenger RNAs, to be spliced in different combinations as the messages are copied from a gene's DNA. Those combinations make different messenger RNAs, which in turn become different proteins.

In stem cells, scientists have shown that a core set of proteins called transcription factors control pluripotency.

The splicing event discovered by Blencowe's team, including first author on the study Dr. Mathieu Gabut, changes the DNA binding properties of FOXP1 in a way that then controls the expression of the core pluripotency transcription factors, to facilitate maintenance of pluripotency. "As a mechanism that controls those core transcription factors, it's right at the heart of the regulatory process of pluripotency," said Blencowe.

At the same time, the mechanism represses the genes required for differentiation—the process whereby by a stem cell loses "stemness" and becomes a specific cell type that makes up an organ or performs a function.

As well, in collaboration with colleagues including Profs. Jeff Wrana and Andras Nagy in the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, also Professors in U of T's Department of Molecular Genetics, the splicing switch identified by Blencowe's team was shown to play a role in "reprogramming," a potentially therapeutic technique in which researchers coax adult cells back into induced pluripotent stem cells by introducing the core transcription factors. "That's an important area in the field where we need better understanding because reprogramming, especially with human cells, is very inefficient," said Blencowe. "Often when reprogrammed stem cells are not fully reprogrammed they become tumorigenic and can lead to cancer."

Potential applications for stem-cell science include growing cells and tissues to test new drugs or to repair or replace damaged tissues in many diseases and conditions, including heart disease, diabetes, spinal cord injury and Alzheimer's disease.

As well, a better understanding of the mechanisms that regulate pluripotency, cell division and differentiation will provide knowledge of how diseases like cancer arise and suggest more targeted therapeutic approaches.

Blencowe and his lab have recently turned their attention to what might be controlling the factors that control both alternative splicing and the maintenance of stem-cell pluripotency. They have, said Blencowe, a few tantalizing glimpses. "There's still a lot to figure out, but I personally believe there is huge potential in the future. If we can fully understand the regulatory controls that allow us to make uniform populations of fully reprogrammed stem cells, there's no reason why they shouldn't be effective for many different therapies. It will come."


###

Funding for the study was provided by the C.H. Best Foundation, the Canadian Cancer Society, the Canadian Institutes of Health Research, Genome Canada through the Ontario Genomics Institute, the National Institutes of Health, the Ontario Ministry of Research and Innovation, and the Ontario Research Fund.

Other co-authors on the study: Payman Samavarchi-Tehrani (Centre for Systems Biology, Samuel Lunenfeld Research Institute, and Dept. of Molecular Genetics, U of T); Xinchen Wang, Valentina Slobodeniuc, Dave O'Hanlon, Shaheynoor Talukder, Qun Pan, and Timothy Hughes (Banting and Best Dept. of Medical Research, U of T, and The Donnelly Centre for Cellular and Biomolecular Research, U of T); Hoon-Ki Sung and Knut Woltjen (Centre for Stem Cells and Tissue Engineering, SLRI); Manuel Alvarez (The Donnelly Centre, and the Institute of Biomaterials and Biomedical Engineering, U of T); Esteban Mazzoni, Stephane Nedelec and Hynek Wichterle (Columbia University Medical Center); Peter Zandstra (The Donnelly Centre and IBBE).







707   Hepatitis C Drugs Await FDA Approval  이성욱 2011/04/26 2301
706   The ghost of personalized medicine  이성욱 2011/07/21 2301
705   유방암의 cyclin D1과 마이크로 알앤에이의 연관성  이성욱 2013/12/05 2305
704   날씬한 마우스의 장내 미생물은 비만 치료제  이성욱 2013/09/11 2306
703   Scientists Map Elusive 3-D Structure of Telomerase Enzyme, Key Actor in Cancer, Aging  이성욱 2013/04/17 2307
702   Tumours grow their own blood vessels  이성욱 2010/11/25 2308
701   이제 미리 초기 간암 전구세포 확인  이성욱 2013/10/14 2309
  Researchers discover a switch that controls stem cell pluripotency  이성욱 2011/09/21 2317
699   What Do Worms Have to Do With Asthma?  이성욱 2011/02/25 2318
698   Scientists use mRNA molecules to create iPS cells  이성욱 2010/10/02 2319
697   Scientists Show How Men Amp Up Their X Chromosome  이성욱 2011/03/07 2319
696   Basel Declaration defends animal research  이성욱 2010/12/10 2320
695   항생제 내성세균의 대안으로 부활하고 있는 박테리오파지 요법  이성욱 2014/06/06 2321
694   그림의 떡 - 한 알에 1,000달러짜리 C형간염 신약 소포스부비어  이성욱 2013/12/20 2323
693   Treatment of Common Virus Can Reduce Tumour Growth, Study Suggests  이성욱 2011/10/04 2325
692   암 줄기세포의 항암제 저항성과의 연관성  이성욱 2014/04/23 2325
691   RNA Controls Splicing During Gene Expression, Further Evidence of 'RNA World' Origin in Modern Life  이성욱 2013/11/07 2327
690   'Patent trolls' target biotechnology firms  이성욱 2011/10/03 2328
689   Vertex hepatitis C drug OK'd, promising more cures  이성욱 2011/05/25 2330
688   인간 난자의 DNA 염기서열을 해독하는 비침습적 방법 개발  이성욱 2013/12/23 2333

[이전 10개] [1]..[21][22][23][24][25][26][27][28] 29 [30]..[64] [다음 10개]
 

Copyright 1999-2022 Zeroboard / skin by ROBIN